These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 22136266)

  • 1. Long-term outcome of comprehensive central compartment dissection in patients with recurrent/persistent papillary thyroid carcinoma.
    Clayman GL; Agarwal G; Edeiken BS; Waguespack SG; Roberts DB; Sherman SI
    Thyroid; 2011 Dec; 21(12):1309-16. PubMed ID: 22136266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Papillary thyroid carcinoma patients assessed to be at low or intermediary risk after primary treatment are at greater risk of long term recurrence if they are thyroglobulin antibody positive or do not have distinctly low thyroglobulin at initial assessment.
    Soyluk O; Boztepe H; Aral F; Alagol F; Özbey NC
    Thyroid; 2011 Dec; 21(12):1301-8. PubMed ID: 22136265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Factors for Re-recurrence After First Reoperative Surgery for Locoregional Recurrent/Persistent Papillary Thyroid Carcinoma.
    Lee HS; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    World J Surg; 2015 Aug; 39(8):1943-50. PubMed ID: 25820911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extranodal extension of metastatic papillary thyroid carcinoma: correlation with biochemical endpoints, nodal persistence, and systemic disease progression.
    Lango M; Flieder D; Arrangoiz R; Veloski C; Yu JQ; Li T; Burtness B; Mehra R; Galloway T; Ridge JA
    Thyroid; 2013 Sep; 23(9):1099-105. PubMed ID: 23421588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment Outcomes and Risk Factors for Recurrence After Definitive Surgery of Locally Invasive Well-Differentiated Papillary Thyroid Carcinoma.
    Kim JW; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Thyroid; 2016 Feb; 26(2):262-70. PubMed ID: 26566765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Routine central lymph node dissection with total thyroidectomy for papillary thyroid cancer potentially minimizes level VI recurrence.
    Hall CM; Snyder SK; Maldonado YM; Lairmore TC
    Surgery; 2016 Oct; 160(4):1049-1058. PubMed ID: 27521047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
    Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
    J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
    Wu MH; Shen WT; Gosnell J; Duh QY
    Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morbidity following central compartment reoperation for recurrent or persistent thyroid cancer.
    Kim MK; Mandel SH; Baloch Z; Livolsi VA; Langer JE; Didonato L; Fish S; Weber RS
    Arch Otolaryngol Head Neck Surg; 2004 Oct; 130(10):1214-6. PubMed ID: 15492172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence of papillary thyroid carcinoma with lateral cervical node metastases: Predictive factors and operative management.
    Chéreau N; Buffet C; Trésallet C; Tissier F; Leenhardt L; Menegaux F
    Surgery; 2016 Mar; 159(3):755-62. PubMed ID: 26435440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central compartment revision surgery for persistent or recurrent thyroid carcinoma: analysis of survival and complication rate.
    Molteni G; Bonali M; Mattioli F; Ghirelli M; Fermi M; Ferri G; Andrea M; Presutti L
    Eur Arch Otorhinolaryngol; 2019 Feb; 276(2):551-557. PubMed ID: 30535975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reoperative lymph node dissection for recurrent papillary thyroid cancer and effect on serum thyroglobulin.
    Hughes DT; Laird AM; Miller BS; Gauger PG; Doherty GM
    Ann Surg Oncol; 2012 Sep; 19(9):2951-7. PubMed ID: 22526913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Repeat of lymphatic dissection for thyroid cancers].
    Mirghani H; Francois A; Landry G; Hans S; Menard M; Brasnu D
    Ann Otolaryngol Chir Cervicofac; 2009 Apr; 126(2):37-42. PubMed ID: 19328459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Algorithm for safe and effective reoperative thyroid bed surgery for recurrent/persistent papillary thyroid carcinoma.
    Farrag TY; Agrawal N; Sheth S; Bettegowda C; Ewertz M; Kim M; Tufano RP
    Head Neck; 2007 Dec; 29(12):1069-74. PubMed ID: 17563908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Level VII is an important component of central neck dissection for papillary thyroid cancer.
    Wang LY; Versnick MA; Gill AJ; Lee JC; Sidhu SB; Sywak MS; Delbridge LW
    Ann Surg Oncol; 2013 Jul; 20(7):2261-5. PubMed ID: 23361896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In papillary thyroid cancer, preoperative central neck ultrasound detects only macroscopic surgical disease, but negative findings predict excellent long-term regional control and survival.
    Moreno MA; Edeiken-Monroe BS; Siegel ER; Sherman SI; Clayman GL
    Thyroid; 2012 Apr; 22(4):347-55. PubMed ID: 22280230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reoperative central compartment dissection for patients with recurrent/persistent papillary thyroid cancer: efficacy, safety, and the association of the BRAF mutation.
    Tufano RP; Bishop J; Wu G
    Laryngoscope; 2012 Jul; 122(7):1634-40. PubMed ID: 22549559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Approach and safety of comprehensive central compartment dissection in patients with recurrent papillary thyroid carcinoma.
    Clayman GL; Shellenberger TD; Ginsberg LE; Edeiken BS; El-Naggar AK; Sellin RV; Waguespack SG; Roberts DB; Mishra A; Sherman SI
    Head Neck; 2009 Sep; 31(9):1152-63. PubMed ID: 19360746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of total thyroidectomy with therapeutic central and lateral neck dissection with a single dose of radioiodine in the treatment of regionally advanced papillary thyroid cancer and effects on serum thyroglobulin.
    Hughes DT; Miller BS; Cohen MS; Doherty GM; Gauger PG
    Ann Surg Oncol; 2014 May; 21(5):1647-52. PubMed ID: 24385210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma.
    Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z
    Clin Transl Oncol; 2019 Nov; 21(11):1482-1491. PubMed ID: 30879178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.